| |
|
|
|
Ocular Therapeut  
|
|
20.03 0.38 (0.02%) |
01-22 16:00 |
|
Open: |
19.41 |
Pre close: |
19.65 |
Target:
|
26.00
|
|
High: |
20.14 |
Low: |
19.4 |
Resistance:
|
22.26
24.30
|
|
Volume: |
719,182 |
Market Cap: |
1508M |
Support:
|
18.97
15.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
20.00
 |
MACD |
MACD(12,26):
|
0.24 |
|
MA(20): |
20.78 |
Signal(12,26,9): |
0.59 |
|
MA(100): |
14.23  |
Stochastic Oscillator |
%K(14,3):
|
17.85 |
|
MA(250): |
9.67 |
%D(3): |
20.24 |
|
Average Volume(K) |
3-Month: |
115217
|
52-Week |
High:
|
24.30 |
|
10-Days: |
77012 |
Low: |
3.78 |
|
RSI |
RSI(14):
|
48.57 |
Change(%): |
365.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.740 |
Return on Equity (ttm) |
-2677.1 |
Shares Out. (M) |
75.30 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-46.8 |
Shares Float (M) |
63.18 |
|
EPS Est. Next Year |
-2.110 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.66 |
|
EPS Est. Next Quarter |
-0.530 |
Qtrly Rev. Growth |
608.8 |
% Held by Institutions |
55.42 |
|
Forward EPS |
-1.910 |
Gross Profit (p.s.) |
-0.520 |
Shares Short (K) |
5000 |
|
Book Value (p.s.) |
-0.060 |
EBITDA (p.s.) |
-0.891 |
P/E |
-11.51 |
|
Sales Per Share |
0.163 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-333.83 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-66.78 |
P/S |
122.52 |
|
Operating Margin |
-567.87 |
Levered Free Cash Flow
(M) |
-40.57 |
P/CF |
-22.59 |
|
|
|
|
|
|
